Related Experiment Video
Updated: May 8, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization
David R Andes1, Daniel K Reynolds, Scott A Van Wart
1Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Abstract:
Echinocandins exhibit concentration-dependent effects on Candida species, and preclinical studies support the administration of large, infrequent doses. The current report examines the pharmacokinetics/pharmacodynamics of two multicenter, randomized trials of micafungin dosing regimens that differed in both dose level and dosing interval. Analysis demonstrates the clinical relevance of the dose level and area under the concentration-time curve (AUC). Better, although not statistically significant (P = 0.056), outcomes were seen with higher maximum concentrations of drug in serum (Cmax) and large, infrequent doses. The results support further clinical investigation of novel micafungin dosing regimens with large doses but less than daily administration. (These studies have been registered at ClinicalTrials.gov under registration no. NCT00666185 and NCT00665639.).
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Overview
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Antifungal Agents
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

